FDA approved Lenvima® (lenvatinib mesylate) in combination with everolimus for the treatment of patients with advanced renal cell carcinoma.
FDA approves Gilotrif® (afatinib) as new oral treatment option for patients with squamous cell carcinoma of the lung
New Drugs and Expanded Indications
Below are postings for new drugs and indications you should be aware of. Please refer to the links below for announcements and details.